CVS director Mike Mahoney, whose day job is CEO of Boston Scientific, bought 30,000 shares of the healthcare company.

For the second year running, nonprofit consulting firm Good Energy applied its Climate Reality Check to the actual ...

Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.

The appointment marks the latest in a spate of leadership changes at CVS as the company’s insurance segment struggles to ...

Ed DeVaney’s promotion is the latest leadership shakeup at CVS Health as the company works on a multi-year turnaround plan.

In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management ...

The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

CVS Health has named Ed DeVaney as president of its pharmacy benefit manager, CVS Caremark. | DeVaney has served as interim ...

CVS Health has eliminated more than 1,000 jobs based at or reporting to its offices in Hartford, which include the ...

Q4 2024 Earnings Call Transcript February 12, 2025 CVS Health Corporation beats earnings expectations. Reported EPS is $1.19, ...

We recently published a list of These 10 Stocks Led Rally on Wednesday. In this article, we are going to take a look at where ...

CVS Health downgraded to Hold due to political risks, declining cash flow, and industry battles despite strong Q4 sales and a ...